• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用结构-活性关系工程设计顺铂纳米颗粒以增强抗肿瘤疗效。

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.

机构信息

Department of Medicine, Brigham and Women's Hospital, Cambridge, MA 02139, USA.

出版信息

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12435-40. doi: 10.1073/pnas.1007026107. Epub 2010 Jun 23.

DOI:10.1073/pnas.1007026107
PMID:20616005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2906605/
Abstract

Cisplatin is a first line chemotherapy for most types of cancer. However, its use is dose-limited due to severe nephrotoxicity. Here we report the rational engineering of a novel nanoplatinate inspired by the mechanisms underlying cisplatin bioactivation. We engineered a novel polymer, glucosamine-functionalized polyisobutylene-maleic acid, where platinum (Pt) can be complexed to the monomeric units using a monocarboxylato and an O --> Pt coordinate bond. We show that at a unique platinum to polymer ratio, this complex self-assembles into a nanoparticle, which releases cisplatin in a pH-dependent manner. The nanoparticles are rapidly internalized into the endolysosomal compartment of cancer cells, and exhibit an IC50 (4.25 +/- 0.16 microM) comparable to that of free cisplatin (3.87 +/- 0.37 microM), and superior to carboplatin (14.75 +/- 0.38 microM). The nanoparticles exhibited significantly improved antitumor efficacy in terms of tumor growth delay in breast and lung cancers and tumor regression in a K-ras(LSL/+)/Pten(fl/fl) ovarian cancer model. Furthermore, the nanoparticle treatment resulted in reduced systemic and nephrotoxicity, validated by decreased biodistribution of platinum to the kidney as quantified using inductively coupled plasma spectroscopy. Given the universal need for a better platinate, we anticipate this coupling of nanotechnology and structure-activity relationship to rationally reengineer cisplatin could have a major impact globally in the clinical treatment of cancer.

摘要

顺铂是大多数类型癌症的一线化疗药物。然而,由于严重的肾毒性,其使用受到剂量限制。在这里,我们报告了一种受顺铂生物活化机制启发的新型纳米铂酸盐的合理工程设计。我们设计了一种新型聚合物,即葡糖胺官能化聚异丁烯-马来酸,其中铂 (Pt) 可以使用单羧酸盐和 O --> Pt 配位键与单体单元络合。我们表明,在独特的铂与聚合物比例下,该复合物自组装成纳米颗粒,以 pH 依赖性方式释放顺铂。这些纳米颗粒迅速被内化到癌细胞的内溶酶体隔间中,并表现出与游离顺铂(3.87 +/- 0.37 microM)相当的 IC50(4.25 +/- 0.16 microM),优于卡铂(14.75 +/- 0.38 microM)。这些纳米颗粒在乳腺癌和肺癌的肿瘤生长延迟以及 K-ras(LSL/+)/Pten(fl/fl)卵巢癌模型中的肿瘤消退方面表现出显著改善的抗肿瘤疗效。此外,纳米颗粒治疗导致全身和肾毒性降低,这通过使用电感耦合等离子体光谱法定量测量铂向肾脏的生物分布减少得到验证。鉴于对更好的铂酸盐的普遍需求,我们预计这种纳米技术和结构-活性关系的结合可以在癌症的临床治疗方面在全球范围内产生重大影响。

相似文献

1
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.利用结构-活性关系工程设计顺铂纳米颗粒以增强抗肿瘤疗效。
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12435-40. doi: 10.1073/pnas.1007026107. Epub 2010 Jun 23.
2
Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy.理性设计的聚合物顺铂纳米颗粒,以提高抗肿瘤疗效。
Nanotechnology. 2011 Jul 1;22(26):265101. doi: 10.1088/0957-4484/22/26/265101. Epub 2011 May 17.
3
Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.合理设计的奥沙利铂纳米颗粒,增强抗肿瘤疗效。
Nanotechnology. 2012 Feb 24;23(7):075103. doi: 10.1088/0957-4484/23/7/075103.
4
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.胆固醇键合的铂 II 基超分子纳米颗粒提高抗肿瘤疗效并降低肾毒性。
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11294-9. doi: 10.1073/pnas.1203129109. Epub 2012 Jun 25.
5
Evaluation of cisplatin and a novel platinum polymer conjugate for drug toxicity and drug distribution in mice.顺铂和一种新型铂聚合物共轭物对小鼠药物毒性和药物分布的评估。
Anticancer Drugs. 2005 Jun;16(5):501-6. doi: 10.1097/00001813-200506000-00005.
6
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
7
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.通过适配体功能化的铂(IV)前药-PLGA-PEG纳米颗粒将顺铂靶向递送至前列腺癌细胞。
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17356-61. doi: 10.1073/pnas.0809154105. Epub 2008 Oct 31.
8
Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.一种具有低肾毒性和遗传毒性的新型铂(II)配合物的抗肿瘤活性
Chem Biol Interact. 2004 Jun 30;148(1-2):37-48. doi: 10.1016/j.cbi.2004.04.002.
9
Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.双乙酸根-氨-二氯-环己胺铂(IV)的临床前抗肿瘤评估:一种口服活性铂类药物
Cancer Res. 1993 Jun 1;53(11):2581-6.
10
[Pharmacological approach to the platinum compounds].[铂化合物的药理学方法]
Gan To Kagaku Ryoho. 1992 Apr;19(4):456-62.

引用本文的文献

1
Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm.新型铂类治疗药物通过触发细胞内 ROS 风暴诱导癌细胞快速死亡。
Biomaterials. 2025 Mar;314:122835. doi: 10.1016/j.biomaterials.2024.122835. Epub 2024 Sep 11.
2
Stability-Enhanced Cisplatin Gold Nanoparticles As Therapeutic Anticancer Agents.稳定性增强的顺铂金纳米颗粒作为治疗性抗癌剂。
ACS Appl Nano Mater. 2024;7(1). doi: 10.1021/acsanm.3c04935.
3
Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer.线粒体功能障碍途径作为人类癌症的一种可能生物标志物和治疗靶点。
Biomed J. 2025 Feb;48(1):100714. doi: 10.1016/j.bj.2024.100714. Epub 2024 Mar 5.
4
(Nano)platforms in bladder cancer therapy: Challenges and opportunities.膀胱癌治疗中的(纳米)平台:挑战与机遇
Bioeng Transl Med. 2022 Jun 17;8(1):e10353. doi: 10.1002/btm2.10353. eCollection 2023 Jan.
5
A spotlight on alkaloid nanoformulations for the treatment of lung cancer.用于治疗肺癌的生物碱纳米制剂研究综述
Front Oncol. 2022 Oct 18;12:994155. doi: 10.3389/fonc.2022.994155. eCollection 2022.
6
Polymer conjugated graphene-oxide nanoparticles impair nuclear DNA and Topoisomerase I in cancer.聚合物共轭氧化石墨烯纳米颗粒损害癌症中的核DNA和拓扑异构酶I。
Nanoscale Adv. 2019 Nov 6;1(12):4965-4971. doi: 10.1039/c9na00617f. eCollection 2019 Dec 3.
7
Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.用于癌症治疗的新一代多功能纳米医学设计的新兴概念。
Biosci Rep. 2022 Jul 29;42(7). doi: 10.1042/BSR20212051.
8
Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles.生物医学中的铂纳米颗粒:制备、抗癌活性及药物递送载体
Front Pharmacol. 2022 Feb 23;13:797804. doi: 10.3389/fphar.2022.797804. eCollection 2022.
9
Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements.卵巢癌的最新进展:治疗策略、潜在生物标志物和技术改进。
Cells. 2022 Feb 13;11(4):650. doi: 10.3390/cells11040650.
10
Serum Metabolic Fingerprints on Bowl-Shaped Submicroreactor Chip for Chemotherapy Monitoring.血清代谢指纹图谱在碗状亚微反应芯片上用于化疗监测。
ACS Nano. 2022 Feb 22;16(2):2852-2865. doi: 10.1021/acsnano.1c09864. Epub 2022 Jan 31.

本文引用的文献

1
Shape effect of carbon nanovectors on angiogenesis.碳纳米载体的形状对血管生成的影响。
ACS Nano. 2010 Jan 26;4(1):574-82. doi: 10.1021/nn901465h.
2
Polymeric drug delivery of platinum-based anticancer agents.铂基抗癌药物的聚合物给药
J Pharm Sci. 2009 Jul;98(7):2299-316. doi: 10.1002/jps.21611.
3
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.通过适配体功能化的铂(IV)前药-PLGA-PEG纳米颗粒将顺铂靶向递送至前列腺癌细胞。
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17356-61. doi: 10.1073/pnas.0809154105. Epub 2008 Oct 31.
4
Intravascular delivery of particulate systems: does geometry really matter?颗粒系统的血管内递送:几何形状真的重要吗?
Pharm Res. 2009 Jan;26(1):235-43. doi: 10.1007/s11095-008-9697-x. Epub 2008 Aug 20.
5
The effect of particle design on cellular internalization pathways.颗粒设计对细胞内化途径的影响。
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8. doi: 10.1073/pnas.0801763105. Epub 2008 Aug 12.
6
Renal clearance of quantum dots.量子点的肾脏清除率。
Nat Biotechnol. 2007 Oct;25(10):1165-70. doi: 10.1038/nbt1340. Epub 2007 Sep 23.
7
The resurgence of platinum-based cancer chemotherapy.基于铂的癌症化疗的复兴。
Nat Rev Cancer. 2007 Aug;7(8):573-84. doi: 10.1038/nrc2167. Epub 2007 Jul 12.
8
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.p63/p73网络在生物学定义的原发性乳腺癌亚群中介导对顺铂的化学敏感性。
J Clin Invest. 2007 May;117(5):1370-80. doi: 10.1172/JCI30866. Epub 2007 Apr 19.
9
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.与基于聚氧乙烯蓖麻油的紫杉醇相比,无聚氧乙烯蓖麻油的白蛋白结合型紫杉醇ABI-007的抗肿瘤活性、肿瘤内紫杉醇浓度及内皮细胞转运均有所增加。
Clin Cancer Res. 2006 Feb 15;12(4):1317-24. doi: 10.1158/1078-0432.CCR-05-1634.
10
Nanotechnology and the developing world.纳米技术与发展中世界
PLoS Med. 2005 May;2(5):e97. doi: 10.1371/journal.pmed.0020097. Epub 2005 Apr 12.